Page last updated: 2024-08-24

topotecan and Malignant Fibrohistiocytic Tumors

topotecan has been researched along with Malignant Fibrohistiocytic Tumors in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Klopfenstein, KJ; Ruymann, FB; Schuller, DE; Scott, S	1

Other Studies

1 other study(ies) available for topotecan and Malignant Fibrohistiocytic Tumors

Article	Year
Prolonged survival with continuous infusion topotecan: a report of 2 cases. Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:6 Topics: Adolescent; Antineoplastic Agents; Carcinoma, Hepatocellular; Child; Child, Preschool; Female; Head and Neck Neoplasms; Histiocytoma, Malignant Fibrous; Humans; Infusions, Intravenous; Liver Neoplasms; Neoplasms, Second Primary; Palliative Care; Survival; Topotecan	2008

Article

Year

Prolonged survival with continuous infusion topotecan: a report of 2 cases.

Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:6

Topics: Adolescent; Antineoplastic Agents; Carcinoma, Hepatocellular; Child; Child, Preschool; Female; Head and Neck Neoplasms; Histiocytoma, Malignant Fibrous; Humans; Infusions, Intravenous; Liver Neoplasms; Neoplasms, Second Primary; Palliative Care; Survival; Topotecan

2008